INFI - Infinity Pharmaceuticals Inc.
Close
0.03
-0.015 -49.000%
Share volume: 0
Last Updated: Wed 13 Sep 2023 07:59:14 PM CEST
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
$0.04
0.00
0.00%
Summary score
38%
Profitability
50%
Dept financing
43%
Liquidity
38%
Performance
25%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 2019 - 2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
90.21%
Return on assets
-18.88%
Return on sales
-2372.49%
Return on invested capital
155.62%
Total debt ratio
101.76%
Debt ratio change over timeo
-0.12%
Current Ratio
5.67%
Quick Ratio
5.67%
Cash Position Ratio
5.46%
Short-term ratios 2022 - 2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
317.19%
Return on assets
-25.39%
Return on sales
-1652.7%
Return on invested capital
95.24%
Total debt ratio
140.66%
Debt ratio change over timeo
0.48%
Current Ratio
3.28%
Quick Ratio
3.28%
Cash Position Ratio
3.09%
Last quarter ratios 2023
The data are presented for the financials results of the last quarter.
Return on equity
39%
Return on assets
-38.42%
Return on sales
-1574.15%
Return on invested capital
113.85%
Total debt ratio
194.56%
Debt ratio change over time
0.71%
Current Ratio
2.51%
Quick Ratio
2.51%
Cash Position Ratio
2.28%
Performance ratios (change over 4 years) 2019 - 2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-11.64%
Return on assets
-115.8%
Return on sales
-1860.25%
Return on invested capital
10.29%
Total debt ratio
-11.7%
Debt ratio change over time
-0.12%
Current Ratio
3.13%
Quick Ratio
3.13%
Cash Position Ratio
2.97%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | INFI | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 90.21% | 0% | 0% | -113.97% |
| Return on assets | -18.88% | 0% | 0% | -11.86% |
| Return on sales | -2372.49% | 0% | 0% | -8138.12% |
| Return on invested capital | 155.62% | 0% | 0% | 12.38% |
| Profitability | 50% | 0% | 50% | 2% |
| Total debt ratio | 101.76% | 0% | 0% | 82.24% |
| Debt ratio change over time | -0.12% | 0% | 0% | -0.64% |
| Dept financing | 25% | 0% | 25% | 20% |
| Current Ratio | 3.28% | 0% | 0% | 8.05% |
| Quick Ratio | 3.28% | 0% | 0% | 8.05% |
| Cash Position Ratio | 3.09% | 0% | 0% | 7.86% |
| Liquididy | 55% | 0% | 0% | 75% |
| Short-term ratios | INFI | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 317.19% | 0% | 0% | -409.38% |
| Return on assets | -25.39% | 0% | 0% | -15.5% |
| Return on sales | -1652.7% | 0% | 0% | -26031.24% |
| Return on invested capital | 95.24% | 0% | 0% | -122.74% |
| Profitability | 50% | 0% | 50% | 0% |
| Total debt ratio | 140.66% | 0% | 0% | 107.48% |
| Debt ratio change over time | 0.48% | 0% | 0% | -1.94% |
| Dept financing | 50% | 0% | 0% | 19% |
| Current Ratio | 3.28% | 0% | 0% | 8.05% |
| Quick Ratio | 3.28% | 0% | 0% | 8.05% |
| Cash Position Ratio | 3.09% | 0% | 0% | 7.86% |
| Liquididy | 30% | 0% | 0% | 75% |